Search

Your search keyword '"Harjola, Veli-Pekka"' showing total 34 results
Start Over Author "Harjola, Veli-Pekka" Journal european journal of heart failure
34 results on '"Harjola, Veli-Pekka"'

1. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Author

Harjola, Veli-Pekka, Mullens, Wilfried, Banaszewski, Marek, Bauersachs, Johann, Brunner-La Rocca, Hans-Peter, Chioncel, Ovidiu, Collins, Sean, Doehner, Wolfram, Filippatos, Gerasimos, Flammer, Andreas, Fuhrmann, Valentin, Lainscak, Mitja, Lassus, Johan, Legrand, Matthieu, Masip, Josep, Mueller, Christian, Papp, Zoltán, Parissis, John, Platz, Elke, Rudiger, Alain, Ruschitzka, Frank, Schäfer, Andreas, Seferovic, Petar, Skouri, Hadi, Yilmaz, Mehmet, and Mebazaa, Alexandre

Subjects
Heart failure, Multiple organ failure, Venous congestion, Acute Disease, Cardiology, Diagnostic Imaging, Disease Management, Europe, Heart Failure, Humans, Multiple Organ Failure, Societies, Medical
Abstract

Organ injury and impairment are commonly observed in patients with acute heart failure (AHF), and congestion is an essential pathophysiological mechanism of impaired organ function. Congestion is the predominant clinical profile in most patients with AHF; a smaller proportion presents with peripheral hypoperfusion or cardiogenic shock. Hypoperfusion further deteriorates organ function. The injury and dysfunction of target organs (i.e. heart, lungs, kidneys, liver, intestine, brain) in the setting of AHF are associated with increased risk for mortality. Improvement in organ function after decongestive therapies has been associated with a lower risk for post-discharge mortality. Thus, the prevention and correction of organ dysfunction represent a therapeutic target of interest in AHF and should be evaluated in clinical trials. Treatment strategies that specifically prevent, reduce or reverse organ dysfunction remain to be identified and evaluated to determine if such interventions impact mortality, morbidity and patient-centred outcomes. This paper reflects current understanding among experts of the presentation and management of organ impairment in AHF and suggests priorities for future research to advance the field.

Published
2017

2. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Author

Chioncel, Ovidiu, primary, Adamo, Marianna, additional, Nikolaou, Maria, additional, Parissis, John, additional, Mebazaa, Alexandre, additional, Yilmaz, Mehmet Birhan, additional, Hassager, Christian, additional, Moura, Brenda, additional, Bauersachs, Johann, additional, Harjola, Veli‐Pekka, additional, Antohi, Elena‐Laura, additional, Ben‐Gal, Tuvia, additional, Collins, Sean P., additional, Iliescu, Vlad Anton, additional, Abdelhamid, Magdy, additional, Čelutkienė, Jelena, additional, Adamopoulos, Stamatis, additional, Lund, Lars H., additional, Cicoira, Mariantonietta, additional, Masip, Josep, additional, Skouri, Hadi, additional, Gustafsson, Finn, additional, Rakisheva, Amina, additional, Ahrens, Ingo, additional, Mortara, Andrea, additional, Janowska, Ewa A., additional, Almaghraby, Abdallah, additional, Damman, Kevin, additional, Miro, Oscar, additional, Huber, Kurt, additional, Ristic, Arsen, additional, Hill, Loreena, additional, Mullens, Wilfried, additional, Chieffo, Alaide, additional, Bartunek, Jozef, additional, Paolisso, Pasquale, additional, Bayes‐Genis, Antoni, additional, Anker, Stefan D., additional, Price, Susanna, additional, Filippatos, Gerasimos, additional, Ruschitzka, Frank, additional, Seferovic, Petar, additional, Vidal‐Perez, Rafael, additional, Vahanian, Alec, additional, Metra, Marco, additional, McDonagh, Theresa A., additional, Barbato, Emanuele, additional, Coats, Andrew J.S., additional, and Rosano, Giuseppe M.C., additional

Published
2023
Full Text
View/download PDF

3. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study

Author

Gayat, Etienne, Arrigo, Mattia, Littnerova, Simona, Sato, Naoki, Parenica, Jiri, Ishihara, Shiro, Spinar, Jindrich, Müller, Christian, Harjola, Veli‐Pekka, Lassus, Johan, Miró, Òscar, Maggioni, Aldo P., AlHabib, Khalid F., Choi, Dong‐Ju, Park, Jin Joo, Zhang, Yuhui, Zhang, Jian, Januzzi, James L., Jr, Kajimoto, Katsuya, Cohen‐Solal, Alain, and Mebazaa, Alexandre

Published
2018
Full Text
View/download PDF

4. Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry

Author

Mebazaa, Alexandre, Motiejunaite, Justina, Gayat, Etienne, Crespo‐Leiro, Maria G., Lund, Lars H., Maggioni, Aldo P., Chioncel, Ovidiu, Akiyama, Eiichi, Harjola, Veli‐Pekka, Seferovic, Petar, Laroche, Cecile, Julve, Marisa Sanz, Roig, Eulalia, Ruschitzka, Frank, and Filippatos, Gerasimos

Published
2018
Full Text
View/download PDF

5. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

Author

Gorter, Thomas M., van Veldhuisen, Dirk J., Bauersachs, Johann, Borlaug, Barry A., Celutkiene, Jelena, Coats, Andrew J.S., Crespo‐Leiro, Marisa G., Guazzi, Marco, Harjola, Veli‐Pekka, Heymans, Stephane, Hill, Loreena, Lainscak, Mitja, Lam, Carolyn S.P., Lund, Lars H., Lyon, Alexander R., Mebazaa, Alexandre, Mueller, Christian, Paulus, Walter J., Pieske, Burkert, Piepoli, Massimo F., Ruschitzka, Frank, Rutten, Frans H., Seferovic, Petar M., Solomon, Scott D., Shah, Sanjiv J., Triposkiadis, Filippos, Wachter, Rolf, Tschöpe, Carsten, and de Boer, Rudolf A.

Published
2018
Full Text
View/download PDF

6. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry

Author

Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Anker, Stefan D., Crespo‐Leiro, Maria G., Harjola, Veli‐Pekka, Parissis, John, Laroche, Cecile, Piepoli, Massimo Francesco, Fonseca, Candida, Mebazaa, Alexandre, Lund, Lars, Ambrosio, Giuseppe A., Coats, Andrew J., Ferrari, Roberto, Ruschitzka, Frank, Maggioni, Aldo P., and Filippatos, Gerasimos

Published
2017
Full Text
View/download PDF

9. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

Author

Harjola, Veli-Pekka, Mebazaa, Alexandre, Čelutkienė, Jelena, Bettex, Dominique, Bueno, Hector, Chioncel, Ovidiu, Crespo-Leiro, Maria G., Falk, Volkmar, Filippatos, Gerasimos, Gibbs, Simon, Leite-Moreira, Adelino, Lassus, Johan, Masip, Josep, Mueller, Christian, Mullens, Wilfried, Naeije, Robert, Nordegraaf, Anton Vonk, Parissis, John, Riley, Jillian P., Ristic, Arsen, Rosano, Giuseppe, Rudiger, Alain, Ruschitzka, Frank, Seferovic, Petar, Sztrymf, Benjamin, Vieillard-Baron, Antoine, Yilmaz, Mehmet Birhan, and Konstantinides, Stavros

Published
2016
Full Text
View/download PDF

12. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology

Author

Chioncel, Ovidiu, primary, Parissis, John, additional, Mebazaa, Alexandre, additional, Thiele, Holger, additional, Desch, Steffen, additional, Bauersachs, Johann, additional, Harjola, Veli‐Pekka, additional, Antohi, Elena‐Laura, additional, Arrigo, Mattia, additional, Ben Gal, Tuvia, additional, Celutkiene, Jelena, additional, Collins, Sean P., additional, DeBacker, Daniel, additional, Iliescu, Vlad A., additional, Jankowska, Ewa, additional, Jaarsma, Tiny, additional, Keramida, Kalliopi, additional, Lainscak, Mitja, additional, Lund, Lars H, additional, Lyon, Alexander R., additional, Masip, Josep, additional, Metra, Marco, additional, Miro, Oscar, additional, Mortara, Andrea, additional, Mueller, Christian, additional, Mullens, Wilfried, additional, Nikolaou, Maria, additional, Piepoli, Massimo, additional, Price, Susana, additional, Rosano, Giuseppe, additional, Vieillard‐Baron, Antoine, additional, Weinstein, Jean M., additional, Anker, Stefan D., additional, Filippatos, Gerasimos, additional, Ruschitzka, Frank, additional, Coats, Andrew J.S., additional, and Seferovic, Petar, additional

Published
2020
Full Text
View/download PDF

13. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology

Author

Harjola, Veli‐Pekka, primary, Parissis, John, additional, Bauersachs, Johann, additional, Brunner‐La Rocca, Hans‐Peter, additional, Bueno, Hector, additional, Čelutkienė, Jelena, additional, Chioncel, Ovidiu, additional, Coats, Andrew J.S., additional, Collins, Sean P., additional, de Boer, Rudolf A., additional, Filippatos, Gerasimos, additional, Gayat, Etienne, additional, Hill, Loreena, additional, Laine, Mika, additional, Lassus, Johan, additional, Lommi, Jyri, additional, Masip, Josep, additional, Mebazaa, Alexandre, additional, Metra, Marco, additional, Miró, Òscar, additional, Mortara, Andrea, additional, Mueller, Christian, additional, Mullens, Wilfried, additional, Peacock, W. Frank, additional, Pentikäinen, Markku, additional, Piepoli, Massimo F., additional, Polyzogopoulou, Effie, additional, Rudiger, Alain, additional, Ruschitzka, Frank, additional, Seferovic, Petar, additional, Sionis, Alessandro, additional, Teerlink, John R., additional, Thum, Thomas, additional, Varpula, Marjut, additional, Weinstein, Jean Marc, additional, and Yilmaz, Mehmet B., additional

Published
2020
Full Text
View/download PDF

14. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology

Author

Čelutkienė, Jelena, primary, Lainscak, Mitja, additional, Anderson, Lisa, additional, Gayat, Etienne, additional, Grapsa, Julia, additional, Harjola, Veli‐Pekka, additional, Manka, Robert, additional, Nihoyannopoulos, Petros, additional, Filardi, Pasquale Perrone, additional, Vrettou, Rosa, additional, Anker, Stefan D., additional, Filippatos, Gerasimos, additional, Mebazaa, Alexandre, additional, Metra, Marco, additional, Piepoli, Massimo, additional, Ruschitzka, Frank, additional, Zamorano, Jose Luis, additional, Rosano, Giuseppe, additional, and Seferovic, Petar, additional

Published
2020
Full Text
View/download PDF

15. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics

Author

Deniau, Benjamin, primary, Rehfeld, Linda, additional, Santos, Karine, additional, Dienelt, Anke, additional, Azibani, Feriel, additional, Sadoune, Malha, additional, Kounde, Paul R., additional, Samuel, Jane L., additional, Tolpannen, Heli, additional, Lassus, Johan, additional, Harjola, Veli‐Pekka, additional, Vodovar, Nicolas, additional, Bergmann, Andreas, additional, Hartmann, Oliver, additional, Mebazaa, Alexandre, additional, and Blet, Alice, additional

Published
2020
Full Text
View/download PDF

17. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology

Author

Mullens, Wilfried, primary, Damman, Kevin, additional, Harjola, Veli‐Pekka, additional, Mebazaa, Alexandre, additional, Brunner‐La Rocca, Hans‐Peter, additional, Martens, Pieter, additional, Testani, Jeffrey M., additional, Tang, W.H. Wilson, additional, Orso, Francesco, additional, Rossignol, Patrick, additional, Metra, Marco, additional, Filippatos, Gerasimos, additional, Seferovic, Petar M., additional, Ruschitzka, Frank, additional, and Coats, Andrew J., additional

Published
2019
Full Text
View/download PDF

18. Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.

Author

Chioncel, Ovidiu, Mebazaa, Alexandre, Maggioni, Aldo P., Harjola, Veli‐Pekka, Rosano, Giuseppe, Laroche, Cecile, Piepoli, Massimo F., Crespo‐Leiro, Maria G., Lainscak, Mitja, Ponikowski, Piotr, Filippatos, Gerasimos, Ruschitzka, Frank, Seferovic, Petar, Coats, Andrew J.S., Lund, Lars H., Auer, J., Ablasser, K., Fruhwald, F., Dolze, T., and Brandner, K.

Subjects
HEART failure, HOSPITAL admission & discharge, PERFUSION, HOSPITAL mortality, CLASSIFICATION
Abstract

Aims: Classification of acute heart failure (AHF) patients into four clinical profiles defined by evidence of congestion and perfusion is advocated by the 2016 European Society of Cardiology (ESC)guidelines. Based on the ESC-EORP-HFA Heart Failure Long-Term Registry, we compared differences in baseline characteristics, in-hospital management and outcomes among congestion/perfusion profiles using this classification.Methods and Results: We included 7865 AHF patients classified at admission as: 'dry-warm' (9.9%), 'wet-warm' (69.9%), 'wet-cold' (19.8%) and 'dry-cold' (0.4%). These groups differed significantly in terms of baseline characteristics, in-hospital management and outcomes. In-hospital mortality was 2.0% in 'dry-warm', 3.8% in 'wet-warm', 9.1% in 'dry-cold' and 12.1% in 'wet-cold' patients. Based on clinical classification at admission, the adjusted hazard ratios (95% confidence interval) for 1-year mortality were: 'wet-warm' vs. 'dry-warm' 1.78 (1.43-2.21) and 'wet-cold' vs. 'wet-warm' 1.33 (1.19-1.48). For profiles resulting from discharge classification, the adjusted hazard ratios (95% confidence interval) for 1-year mortality were: 'wet-warm' vs. 'dry-warm' 1.46 (1.31-1.63) and 'wet-cold' vs. 'wet-warm' 2.20 (1.89-2.56). Among patients discharged alive, 30.9% had residual congestion, and these patients had higher 1-year mortality compared to patients discharged without congestion (28.0 vs. 18.5%). Tricuspid regurgitation, diabetes, anaemia and high New York Heart Association class were independently associated with higher risk of congestion at discharge, while beta-blockers at admission, de novo heart failure, or any cardiovascular procedure during hospitalization were associated with lower risk of residual congestion.Conclusion: Classification based on congestion/perfusion status provides clinically relevant information at hospital admission and discharge. A better understanding of the clinical course of the two entities could play an important role towards the implementation of targeted strategies that may improve outcomes. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

19. Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Author

Harjola, Veli‐Pekka, primary, Parissis, John, additional, Brunner‐La Rocca, Hans‐Peter, additional, Čelutkienė, Jelena, additional, Chioncel, Ovidiu, additional, Collins, Sean P., additional, De Backer, Daniel, additional, Filippatos, Gerasimos S., additional, Gayat, Etienne, additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lassus, Johan, additional, Masip, Josep, additional, Mebazaa, Alexandre, additional, Miró, Òscar, additional, Mortara, Andrea, additional, Mueller, Christian, additional, Mullens, Wilfried, additional, Nieminen, Markku S., additional, Rudiger, Alain, additional, Ruschitzka, Frank, additional, Seferovic, Petar M., additional, Sionis, Alessandro, additional, Vieillard‐Baron, Antoine, additional, Weinstein, Jean Marc, additional, de Boer, Rudolf A., additional, Crespo‐Leiro, Maria G., additional, Piepoli, Massimo, additional, and Riley, Jillian P., additional

Published
2018
Full Text
View/download PDF

20. Corrigendum to ‘Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology’ [Eur J He

Author

Corrà, Ugo, primary, Agostoni, Pier Giuseppe, additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Crespo Leiro, Maria G., additional, de Boer, Rudolph A., additional, Harjola, Veli-Pekka, additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lund, Lars H., additional, Metra, Marco, additional, Ponikowski, Piotr, additional, Riley, Jillian, additional, Seferović, Petar M., additional, and Piepoli, Massimo F., additional

Published
2018
Full Text
View/download PDF

21. The BRONCH-AHF study: effects on short-term outcome of nebulized bronchodilators in emergency department patients diagnosed with acute heart failure.

Author

Miró, Òscar, Tost, Josep, Gil, Víctor, Martín‐Sánchez, Francisco Javier, Llorens, Pere, Herrero, Pablo, Mebazaa, Alexandre, Harjola, Veli‐Pekka, Ríos, José, Marco‐Hernández, Javier, Collins, Sean P., Peacock, W. Frank, Hollander, Judd E., Lorca, María T., Jacob, Javier, on behalf of the ICA‐SEMES Research Group, Martín-Sánchez, Francisco Javier, Harjola, Veli-Pekka, Marco-Hernández, Javier, and ICA-SEMES Research Group

Subjects
BRONCHODILATOR agents, AEROSOLS, HEART failure, DIURETICS, DYSPNEA, DRUG therapy for asthma, ASTHMA, COMPARATIVE studies, HOSPITAL emergency services, LONGITUDINAL method, OBSTRUCTIVE lung diseases, RESEARCH methodology, MEDICAL cooperation, RESEARCH, RESPIRATORY therapy equipment, TIME, EVALUATION research, DISEASE incidence, ACUTE diseases, DISEASE complications, DIAGNOSIS
Published
2018
Full Text
View/download PDF

22. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality.

Author

Tarvasmäki, Tuukka, Haapio, Mikko, Mebazaa, Alexandre, Sionis, Alessandro, Silva‐Cardoso, José, Tolppanen, Heli, Lindholm, Matias Greve, Pulkki, Kari, Parissis, John, Harjola, Veli‐Pekka, Lassus, Johan, on behalf of the CardShock Study Investigators, Silva-Cardoso, José, Harjola, Veli-Pekka, and CardShock Study Investigators

Subjects
CARDIOGENIC shock, HEMODYNAMIC monitoring, KIDNEY injuries, CREATININE, MORTALITY
Abstract

Copyright of European Journal of Heart Failure is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2018
Full Text
View/download PDF

23. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

Author

Gorter, Thomas M., primary, van Veldhuisen, Dirk J., additional, Bauersachs, Johann, additional, Borlaug, Barry A., additional, Celutkiene, Jelena, additional, Coats, Andrew J.S., additional, Crespo‐Leiro, Marisa G., additional, Guazzi, Marco, additional, Harjola, Veli‐Pekka, additional, Heymans, Stephane, additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lam, Carolyn S.P., additional, Lund, Lars H., additional, Lyon, Alexander R., additional, Mebazaa, Alexandre, additional, Mueller, Christian, additional, Paulus, Walter J., additional, Pieske, Burkert, additional, Piepoli, Massimo F., additional, Ruschitzka, Frank, additional, Rutten, Frans H., additional, Seferovic, Petar M., additional, Solomon, Scott D., additional, Shah, Sanjiv J., additional, Triposkiadis, Filippos, additional, Wachter, Rolf, additional, Tschöpe, Carsten, additional, and de Boer, Rudolf A., additional

Published
2017
Full Text
View/download PDF

24. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology

Author

Corrà, Ugo, primary, Agostoni, Pier Giuseppe, additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Crespo Leiro, Maria G., additional, de Boer, Rudolph A., additional, Harjola, Veli-Pekka, additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lund, Lars H., additional, Metra, Marco, additional, Ponikowski, Piotr, additional, Riley, Jillian, additional, Seferović, Petar M., additional, and Piepoli, Massimo F., additional

Published
2017
Full Text
View/download PDF

25. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.

Author

Corrà, Ugo, Agostoni, Pier Giuseppe, Anker, Stefan D., Coats, Andrew J. S., Crespo Leiro, Maria G., de Boer, Rudolph A., Hairola, Veli‐Pekka, Hill, Loreena, Lainscak, Mitja, Lund, Lars H., Metra, Marco, Ponikowski, Piotr, Riley, Jillian, Seferović, Petar M., Piepoli, Massimo F., Hairola, Veli-Pekka, and Harjola, Veli-Pekka

Subjects
HEART failure treatment, CARDIOPULMONARY fitness, VENTRICULAR ejection fraction, QUALITY of life
Abstract

Traditionally, the main indication for cardiopulmonary exercise testing (CPET) in heart failure (HF) was for the selection of candidates to heart transplantation: CPET was mainly performed in middle-aged male patients with HF and reduced left ventricular ejection fraction. Today, CPET is used in broader patients' populations, including women, elderly, patients with co-morbidities, those with preserved ejection fraction, or left ventricular assistance device recipients, i.e. individuals with different responses to incremental exercise and markedly different prognosis. Moreover, the diagnostic and prognostic utility of symptom-limited CPET parameters derived from submaximal tests is more and more considered, since many patients are unable to achieve maximal aerobic power. Repeated tests are also being used for risk stratification and evaluation of intervention, so that these data are now available. Finally, patients, physicians and healthcare decision makers are increasingly considering how treatments might impact morbidity and quality of life rather than focusing more exclusively on hard endpoints (such as mortality) as was often the case in the past. Innovative prognostic flowcharts, with CPET at their core, that help optimize risk stratification and the selection of management options in HF patients, have been developed. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

26. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergenc

Author

Mebazaa, Alexandre, primary, Yilmaz, M. Birhan, additional, Levy, Phillip, additional, Ponikowski, Piotr, additional, Peacock, W. Frank, additional, Laribi, Said, additional, Ristic, Arsen D., additional, Lambrinou, Ekaterini, additional, Masip, Josep, additional, Riley, Jillian P., additional, McDonagh, Theresa, additional, Mueller, Christian, additional, deFilippi, Christopher, additional, Harjola, Veli-Pekka, additional, Thiele, Holger, additional, Piepoli, Massimo F., additional, Metra, Marco, additional, Maggioni, Aldo, additional, McMurray, John, additional, Dickstein, Kenneth, additional, Damman, Kevin, additional, Seferovic, Petar M., additional, Ruschitzka, Frank, additional, Leite-Moreira, Adelino F., additional, Bellou, Abdelouahab, additional, Anker, Stefan D., additional, and Filippatos, Gerasimos, additional

Published
2015
Full Text
View/download PDF

27. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Author

Ponikowski, Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G. F., Coats, Andrew J. S., Falk, Volkmar, González‐Juanatey, José Ramón, Harjola, Veli‐Pekka, Jankowska, Ewa A., Jessup, Mariell, Linde, Cecilia, Nihoyannopoulos, Petros, Parissis, John T., Pieske, Burkert, Riley, Jillian P., Rosano, Giuseppe M. C., Ruilope, Luis M., Ruschitzka, Frank, and Rutten, Frans H.

Subjects
HEART failure, HEART failure treatment, CHRONIC diseases, ECHOCARDIOGRAPHY, DRUG therapy, DIAGNOSIS, CARDIOVASCULAR agents, ARTIFICIAL blood circulation, DIAGNOSTIC imaging, HEART transplantation, HEART function tests, ACUTE diseases, STROKE volume (Cardiac output), DISEASE complications, THERAPEUTICS
Published
2016
Full Text
View/download PDF

31. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II

Author

Nieminen, Markku S., primary, Harjola, Veli-Pekka, additional, Hochadel, Matthias, additional, Drexler, Helmut, additional, Komajda, Michel, additional, Brutsaert, Dirk, additional, Dickstein, Kenneth, additional, Ponikowski, Piotr, additional, Tavazzi, Luigi, additional, Follath, Ferenc, additional, and Lopez-Sendon, Jose Luis, additional

Published
2008
Full Text
View/download PDF

33. Recommendations on pre-hospitalearly hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine

Author

Ekaterini Lambrinou, Kenneth Dickstein, Holger Thiele, Alexandre Mebazaa, Theresa McDonagh, Stefan D. Anker, Gerasimos Filippatos, Aldo P. Maggioni, Arsen D. Ristić, Phillip D. Levy, Jillian P. Riley, Massimo F Piepoli, Said Laribi, Abdelouahab Bellou, John J.V. McMurray, Adelino F. Leite-Moreira, Kevin Damman, Marco Metra, Josep Masip, W. Frank Peacock, M. Birhan Yilmaz, Piotr Ponikowski, Veli-Pekka Harjola, Christopher DeFilippi, Christian Mueller, Petar M. Seferovic, Frank Ruschitzka, Λαμπρινού, Αικατερίνη, [Mebazaa, Alexandre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U942,Hop Lariboisiere,St Louis Univ Hosp, Paris, France -- [Yilmaz, M. Birhan] Cumhuriyet Univ, Fac Med, Dept Cardiol, TR-58140 Sivas, Turkey -- [Levy, Phillip] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA -- [Levy, Phillip] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA -- [Ponikowski, Piotr] Wroclaw Med Univ, Mil Hosp 4, PL-50981 Wroclaw, Poland -- [Peacock, W. Frank] Baylor Coll Med, Ben Taub Gen Hosp, Houston, TX 77030 USA -- [Laribi, Said] Grp Hosp St Louis Lariboisiere, AP HP, INSERM, U942, Paris, France -- [Ristic, Arsen D.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia -- [Ristic, Arsen D.] Univ Belgrade, Sch Med, Belgrade, Serbia -- [Lambrinou, Ekaterini] Cyprus Univ Technol, Sch Hlth Sci, Dept Nursing, Limassol, Cyprus -- [Masip, Josep] Univ Barcelona, Hosp St Joan Despi Moises Broggi, Consorci Sanitari Integral, Barcelona, Spain -- [Masip, Josep] Univ Barcelona, Hosp Gen Hosp, Barcelona, Spain -- [Riley, Jillian P.] Univ London Imperial Coll Sci Technol & Med, London, England -- [McDonagh, Theresa] Kings Coll Hosp London, London, England -- [Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland -- [deFilippi, Christopher] Univ Maryland, Sch Med, Div Cardiovasc Med, Baltimore, MD 21201 USA -- [Harjola, Veli-Pekka] Univ Helsinki, Helsinki Univ Hosp, Emergency Med, Helsinki, Finland -- [Thiele, Holger] Med Univ Lubeck, Univ Hosp Schleswig Holstein, Med Clin 2, D-23538 Lubeck, Germany -- [Piepoli, Massimo F.] AUSL Piacenza, Guglielmo da Saliceto Hosp, Dept Cardiac, Heart Failure Unit, Piacenza, Italy -- [Metra, Marco] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Cardiol, Brescia, Italy -- [Maggioni, Aldo] ANMCO Resarch Ctr, Florence, Italy -- [McMurray, John J. V.] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland -- [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Bergen, Norway -- [Damman, Kevin] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands -- [Seferovic, Petar M.] Univ Belgrade, Fac Med, Belgrade, Serbia -- [Seferovic, Petar M.] Univ Med Ctr, Dept Cardiol, Belgrade, Serbia -- [Ruschitzka, Frank] Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland -- [Leite-Moreira, Adelino F.] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal -- [Leite-Moreira, Adelino F.] Ctr Hosp Sao Joao, Dept Cardiothorac Surg, Oporto, Portugal -- [Bellou, Abdelouahab] Harvard Univ, Sch Med, Boston, MA USA -- [Bellou, Abdelouahab] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA -- [Bellou, Abdelouahab] Univ Rennes 1, Fac Med, Rennes, France -- [Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany -- [Anker, Stefan D.] Univ Med Ctr Gottingen UMG, Dept Cardiol, Div Innovat Clin Trials, Gottingen, Germany -- [Filippatos, Gerasimos] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Cardiol, GR-11527 Athens, Greece, YILMAZ, MEHMET BIRHAN -- 0000-0002-8169-8628, YILMAZ, Mehmet Birhan -- 0000-0002-8169-8628, Leite-Moreira, Adelino -- 0000-0001-7808-3596, piepoli, massimo francesco -- 0000-0003-1124-234X, Ponikowski, Piotr -- 0000-0002-3391-7064, Mebazaa, Alexandre -- 0000-0001-8715-7753, mcmurray, john -- 0000-0002-6317-3975, Bellou, Abdelouahab -- 0000-0003-3457-5585, University of Zurich, Mebazaa, Alexandre, Cardiovascular Centre (CVC), and [Mebazaa, Alexandre] Univ Paris Diderot, Lariboisiere St Louis Univ Hosp, AP HP, Sorbonne Paris Cite, Paris, France -- [Yilmaz, M. Birhan] Cumhuriyet Univ, Fac Med, Dept Cardiol, TR-58140 Sivas, Turkey -- [Levy, Phillip] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA -- [Levy, Phillip] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA -- [Ponikowski, Piotr] Wroclaw Med Univ, Mil Hosp 4, PL-50981 Wroclaw, Poland -- [Peacock, W. Frank] Ben Taub Gen Hosp, Baylor Coll Med, Houston, TX 77030 USA -- [Laribi, Said] INSERM, UMRS 942, Paris, France -- [Ristic, Arsen D.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia -- [Ristic, Arsen D.] Univ Belgrade, Sch Med, Belgrade, Serbia -- [Lambrinou, Ekaterini] Cyprus Univ Technol, Sch Hlth Sci, Dept Nursing, Limassol, Cyprus -- [Masip, Josep] Univ Barcelona, Hosp St Joan DespiMoises Broggi, Consorci Sanitari Integral, Barcelona, Spain -- [Masip, Josep] Univ Barcelona, Hosp Gen Hosp, Barcelona, Spain -- [Riley, Jillian P.] Univ London Imperial Coll Sci Technol & Med, London, England -- [McDonagh, Theresa] Kings Coll Hosp London, London, England -- [Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland -- [deFilippi, Christopher] Univ Maryland, Sch Med, Div Cardiovasc Med, Baltimore, MD 21201 USA -- [Harjola, Veli-Pekka] Univ Helsinki, Helsinki Univ Hosp, Emergency Med, Helsinki, Finland -- [Thiele, Holger] Med Univ Lubeck, Univ Hosp Schleswig Holstein, Med Clin 2, D-23538 Lubeck, Germany -- [Piepoli, Massimo F.] AUSL Piacenza, Guglielmo da Saliceto Hosp, Dept Cardiac, Heart Failure Unit, Piacenza, Italy -- [Metra, Marco] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Cardiol, Brescia, Italy -- [Maggioni, Aldo] ANMCO Resarch Ctr, Fireze, Italy -- [McMurray, John] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland -- [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Bergen, Norway -- [Damman, Kevin] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands -- [Seferovic, Petar M.] Univ Belgrade, Fac Med, Belgrade, Serbia -- [Seferovic, Petar M.] Univ Med Ctr, Dept Cardiol, Belgrade, Serbia -- [Ruschitzka, Frank] Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland -- [Leite-Moreira, Adelino F.] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal -- [Leite-Moreira, Adelino F.] Ctr Hosp Sao Joao, Dept Cardiothorac Surg, Oporto, Portugal -- [Bellou, Abdelouahab] Harvard Univ, Sch Med, Boston, MA USA -- [Bellou, Abdelouahab] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA -- [Bellou, Abdelouahab] Univ Rennes 1, Fac Med, Rennes, France -- [Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany -- [Anker, Stefan D.] Univ Med Ctr Groningen, Dept Cardiol, Div Innovat Clin Trials, Gottingen, Germany -- [Filippatos, Gerasimos] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Cardiol, GR-11527 Athens, Greece

Subjects
Male, Cardiac Care Facilities, vasodilators, Vasodilator Agents, law.invention, 0302 clinical medicine, DESIGN, CLINICAL CHARACTERISTICS, Health care, Myocardial infarction, Diuretics, Societies, Medical, Emergency Service, OUTCOMES, Evidence-Based Medicine, Respiration, cardiogenic shock, 3. Good health, Administration, Artificial, Acute Disease, 10209 Clinic for Cardiology, Emergency medicine, TRIAL, Emergency Service, Hospital, Cardiology and Cardiovascular Medicine, Oral, medicine.medical_specialty, Infusions, ACUTE MYOCARDIAL-INFARCTION, Shock, Cardiogenic, Heart failure, Acute, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, Hospital, Intensive care, Medical, Humans, Intensive care medicine, Aged, Heart Failure, Clinical Laboratory Techniques, NATRIURETIC PEPTIDE, Oxygen Inhalation Therapy, Administration, Oral, Algorithms, Consensus, Critical Care, Emergency Medical Services, Female, Heart-Assist Devices, Hospitalization, Infusions, Intravenous, Nurse's Role, Oxygen, Patient Discharge, Respiration, Artificial, Evidence-based medicine, medicine.disease, Coronary care unit, Coronary care units, Treatment decision making, Clinical Medicine, TASK-FORCE, Hospital setting, RATIONALE, 030204 cardiovascular system & hematology, Medical and Health Sciences, Health administration, law, 030212 general & internal medicine, Cardiogenic shock, ISOSORBIDE-DINITRATE, Vasodilators, Shock, Intensive care unit, Europe, Practice Guidelines as Topic, Emergency Medicine, Noninvasive ventilation, Medical emergency, Intravenous, Cardiology, Context (language use), 610 Medicine & health, NONINVASIVE VENTILATION, CARDIOGENIC PULMONARY-EDEMA, medicine, Task force, business.industry, Acute heart failure, diuretics, Emergency department, Cardiogenic, SCIENTIFIC STATEMENT, Hospital administration, RELAX-AHF, Societies, business
Abstract

WOS: 000356799600005, PubMed ID: 25999021, Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide optimal benefit. However, many treatment decisions are opinion-based and few are evidenced-based. This consensus paper provides guidance to practicing physicians and nurses to manage acute heart failure in the pre-hospital and hospital setting. Criteria of hospitalization and of discharge are described. Gaps in knowledge and perspectives in the management of acute heart failure are also detailed. This consensus paper on acute heart failure might help enable contiguous practice., Bayer; Cardiorentis; Medicine Company; Critical Diagnostics; Novartis; Steering Committee member of Cardiorentis; TUBITAK; Medicines Company; Cornerstone Therapeutics; Otsuka; Janssen; Apex Innovations; Inte-Section Medical; Trevena; Vifor Pharma Ltd; Amgen; Servier; Abbott Vascular; Coridea; Respicardia; Swiss National Science Foundation; Swiss Heart Foundation; Cardiovascular Research Foundation Basel; 8sense; Abbott; ALERE; Brahms; Nanosphere; Roche; Siemens; University Hospital Basel; Astra Zeneca; BG medicine; Biomerieux; Lilly; Orion; Resmed; Roche Diagnostics; Ratiopharm; BMS; Boehringer-Ingelheim; Pfizer; Daiichi Sankyo; Boehinger Ingelheim; AstraZeneca; European Union, A.M. received speaker's honoraria from Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, Vifor Pharma and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicine Company, Critical Diagnostics.; M.B.Y. received speaker's honoraria and research fee from Novartis and received fee as Steering Committee member of Cardiorentis, and is supported by TUBITAK.; P.L. received speaker's honoraria from Beckman Coulter and Novartis and also received fees as a member of advisory board and/or Steering Committee from Bayer, Cardiorentis, The Medicines Company, Cornerstone Therapeutics, Novartis, Otsuka, Janssen, Apex Innovations, Inte-Section Medical, and Trevena.; P.P. received speaker's honoraria from Bayer, Novartis, Servier, Vifor Pharma, Amgen, Pfizer, Cardiorentis, Merck-Serono, Abbott Vascular and Respicardia and also received fee as member of advisory board and/or Steering Committee from Bayer, Cardiorentis, Novartis, Vifor Pharma Ltd, Amgen, Servier, Abbott Vascular, Coridea and Respicardia.; E.L. received consultancy fee from Novartis.; J.M. received honoraria for speaker or advisor from Abbott, Novartis, Orion, Otsuka, and Sanofi and fee as a member of Steering Committee from Corthera, Novartis, and Cardiorentis.; C.M. received research grants from the Swiss National Science Foundation and the Swiss Heart Foundation, the Cardiovascular Research Foundation Basel, 8sense, Abbott, ALERE, Brahms, Critical Diagnostics, Nanosphere, Roche, Siemens, and the University Hospital Basel, as well as speaker/consulting honoraria from Astra Zeneca, Abbott, ALERE, BG medicine, Biomerieux, Brahms, Cardiorentis, Lilly, Novartis, Pfizer, Roche, and Siemens.; V.P.H. received speaker's fee: Bayer, Orion, Resmed, Roche Diagnostics, Ratiopharm; consultation fees: Bayer, BMS, Boehringer-Ingelheim, Novartis, Pfizer, Roche Diagnostics, Servier. H.A.T. received speaker's honoraria from Daiichi Sankyo, Lilly, Medicines Company, AstraZeneca, Boehinger Ingelheim. Advisory board for Maquet Cardiovascular. Institutional research support by Maquet Cardiovascular, Teleflex, Terumo, Lilly, The Medicine Company.; G.F. has received research grants and/or has served as Committee member or Cochair of studies sponsored by Bayer, Novartis, Cardiorentis, Vifor Pharma, and the European Union.

Published
2014

34. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardio

Author

John Parissis, Jean Marc Weinstein, Gerasimos Filippatos, Veli-Pekka Harjola, Massimo F Piepoli, Etienne Gayat, Josep Masip, Antoine Vieillard-Baron, Òscar Miró, Christian Mueller, Petar M. Seferovic, Alexandre Mebazaa, Wilfried Mullens, Johan Lassus, Rudolf A. de Boer, Jillian P. Riley, Daniel De Backer, Andrea Mortara, Alain Rudiger, Hans-Peter Brunner-La Rocca, María G. Crespo-Leiro, Ovidiu Chioncel, Sean P. Collins, Markku S. Nieminen, Jelena Celutkiene, Loreena Hill, Mitja Lainscak, Alessandro Sionis, Frank Ruschitzka, RS: CARIM - R2.02 - Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), Cardiologie, HUS Emergency Medicine and Services, Clinicum, Anestesiologian yksikkö, Department of Diagnostics and Therapeutics, HUS Heart and Lung Center, Kardiologian yksikkö, Department of Medicine, University of Zurich, Harjola, Veli-Pekka, and Cardiovascular Centre (CVC)

Subjects
Biomedical Research, RESPIRATORY-DISTRESS-SYNDROME, 030204 cardiovascular system & hematology, 0302 clinical medicine, LONG-TERM OUTCOMES, Medicine, Societies, Medical, ARTERY CATHETERIZATION EFFECTIVENESS, physiologic, EMERGENCY-DEPARTMENT PATIENTS, 3. Good health, Europe, Clinical Practice, Acute Disease, Practice Guidelines as Topic, 10209 Clinic for Cardiology, Cardiology, 10023 Institute of Intensive Care Medicine, Cardiology and Cardiovascular Medicine, CRITICALLY-ILL PATIENTS, Heart failure, Monitoring, physiologic, Inpatients, VENTRICULAR FILLING PRESSURES, medicine.medical_specialty, Monitoring, 10216 Institute of Anesthesiology, 610 Medicine & health, RIGHT ATRIAL PRESSURE, 2705 Cardiology and Cardiovascular Medicine, Disease course, 03 medical and health sciences, CARDIOGENIC PULMONARY-EDEMA, Intensive care, Internal medicine, Humans, Monitoring, Physiologic, Monitoring physiologic, Inpatient, Heart Failure, business.industry, 030208 emergency & critical care medicine, Guideline, Emergency department, Evidence-based medicine, WORSENING RENAL-FUNCTION, medicine.disease, 3121 General medicine, internal medicine and other clinical medicine, Coronary care unit, business, REDUCED EJECTION FRACTION
Abstract

This paper provides a practical clinical application of guideline recommendations relating to the inpatient monitoring of patients with acute heart failure, through the evaluation of various clinical, biomarker, imaging, invasive and non-invasive approaches. Comprehensive inpatient monitoring is crucial to the optimal management of acute heart failure patients. The European Society of Cardiology heart failure guidelines provide recommendations for the inpatient monitoring of acute heart failure, but the level of evidence underpinning most recommendations is limited. Many tools are available for the in-hospital monitoring of patients with acute heart failure, and each plays a role at various points throughout the patient's treatment course, including the emergency department, intensive care or coronary care unit, and the general ward. Clinical judgment is the preeminent factor guiding application of inpatient monitoring tools, as the various techniques have different patient population targets. When applied appropriately, these techniques enable decision making. However, there is limited evidence demonstrating that implementation of these tools improves patient outcome. Research priorities are identified to address these gaps in evidence. Future research initiatives should aim to identify the optimal in-hospital monitoring strategies that decrease morbidity and prolong survival in patients with acute heart failure. The authors acknowledge the Heart Failure Association of theEuropean Society of Cardiology for organizing the meeting duringwhich this topic was discussed.The authors acknowledge Wendy Gattis Stough, PharmD(Campbell University College of Pharmacy and Health Sciences),supported by the Heart Failure Association of the EuropeanSociety of Cardiology for contributions to content development,writing, and editing the manuscript.The work of JelenaˇCelutkien ̇e was supported by the grant fromLithuanian Research Council Nr. MIP-049/2015.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results